Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (propiolactone Inactivated)
Generic Name: influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (propiolactone inactivated), influenza a virus a/croatia/10136rv/2023 x-425a (h3n2) antigen (propiolactone inactivated), influenza b virus b/austria/1359417/2021 bvr-26 antigen (propiolactone inactivated)
Brand Names:
Afluria
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) (15 ug/.5mL); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED) (15 ug/.5mL); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) (15 ug/.5mL). Category: BLA.
Overview
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED) (15 ug/.5mL); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED) (15 ug/.5mL); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED) (15 ug/.5mL). Category: BLA.
Dosage
Available as injection, suspension for intramuscular use.
Related Medications
Wyethia Helenioides
wyethia helenioides
Uses Temporarily relieves discomfort and irritation in the throat.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Ascorbic Acid - Dodecahydroxycyclohexane Dihydrate - Fucus Vesiculosus - Histidine Monohydrochloride - Human Interleukin-6 (nonglycosylated) - Hyaluronidase - Lactic Acid, Dl - Malic Acid - Nadide - Phenylalanine - Prasterone - Prolactin - Rancid Beef - Sodium Diethyl Oxalacetate - Sodium Pyruvate - Sodium Sulfate - Sus Scrofa Conjunctiva - Sus Scrofa Small Intestine Mucosa Lymph Follicle - Thuja Occidentalis Twig - Tyrosine -
ascorbic acid - dodecahydroxycyclohexane dihydrate - fucus vesiculosus - histidine monohydrochloride - human interleukin-6 (nonglycosylated) - hyaluronidase - lactic acid, dl - malic acid - nadide - phenylalanine - prasterone - prolactin - rancid beef - sodium diethyl oxalacetate - sodium pyruvate - sodium sulfate - sus scrofa conjunctiva - sus scrofa small intestine mucosa lymph follicle - thuja occidentalis twig - tyrosine -
Vitamin C [EPC]
USES Temporary Relief of general symptoms and inflammatory symptoms related to excess toxin buildup, such as: Fatigue Occasionale muscle aches and pains Skin rashes Swelling
Fulvestrant
fulvestrant
Estrogen Receptor Antagonist [EPC]
Fulvestrant is an estrogen receptor antagonist indicated for hormone receptor-positive, HER2-negative advanced breast cancer in postmenopausal women, available as monotherapy or in combination with CDK4/6 inhibitors.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.